刊名:Journal of Huazhong University of Science and Technology [Medical Sciences]
出版年:2010
出版时间:October 2010
年:2010
卷:30
期:5
页码:575-581
全文大小:668KB
参考文献:1. Beckman JA, Greager MA, Libby P. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA, 2002,287(19):2570-581 CrossRef 2. Yarom R, Zirkin H, Stammler G, / et al. Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material. J Pathol, 1992,166(3):265-70 CrossRef 3. Kohler HP, Grant PJ. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med, 2000,342(24):1792-801 CrossRef 4. Carr ME. Diabetes mellitus: a hypercoagulable state. J Diabetes Complications, 2001,15(1):44-4 CrossRef 5. Boeri D, Maiello M, Lorenzi M. Increased prevalence of microthromboses in retinal capillaries of diabetic individuals. Diabetes, 2001,50(6):1432-439 CrossRef 6. Levy GA, Liu M, Ding J, / et al. Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis. Am J Pathol, 2000,156(4):1217-225 7. Chan CW, Chan MW, Liu M, / et al. Kinetic analysis of a unique direct prothrombinase, fgl2, and identification of a serine residue critical for the prothrombinase activity. J Immunol, 2002,168(10):5170-177 8. Ding JW, Ning Q, Liu MF, / et al. Fulminant hepatic failure in murine hepatitis virus strain 3 infection: Tissue-specific expression of a novel fgl2 prothrombinase. J Virol, 1997,71(12):9223-230 9. Marsden PA, Ning Q, Fung LS, / et al. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest, 2003,112(1):58-6 10. Ghanekar A, Mendicino M, Liu H, / et al. Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection. J Immunol, 2004,172(9): 5693-701 11. Mendicino M, Liu M, Ghanekar A, / et al. Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenografts. Circulation, 2005,112(2):248-56 CrossRef 12. Clark DA, Ding JW, Chaouat G, / et al. The emerging role of immunoregulation of fibrinogen-related procoagulant Fgl2 in the success or spontaneous abortion of early pregnancy in mice and humans. Am J Reprod Immunol, 1999,42(1):37-3 13. Knackstedt MK, Zenclussen AC, Hertwig K, / et al. Th1 cytokines and the prothrombinase fgl2 in stress-tri ggered and inflammatory abortion. Am J Reprod Immunol, 2003,49(4):210-20 CrossRef 14. Clark DA, Foerster K, Fung L, / et al. The fgl2 prothrombinase/fibroleukin gene is required for lipopolysaccharide-triggered abortions and for normal mouse reproduction. Mol Hum Reprod, 2004,10(2):99-08 CrossRef 15. Luo J, Quan J, Tsai J, / et al. Nongenetic mouse models of non-insulin-dependent diabetes mellitus. Metabolism, 1998,47(6):663-68 CrossRef 16. Doolittle RF. The structure and evolution of vertebrate fibrinogen. Ann N Y Acad Sci, 1983,408:13-7 CrossRef 17. Levy GA, Marsden P, Zhong R, / et al. Strategies to prevent thrombosis in xenotransplants. Transplant Proc, 1998,30(5):2458-460 CrossRef 18. Ning Q, Brown D, Parodo J, / et al. Ribavirin inhibits viral-induced macrophage production of TNF-α, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol, 1998,160(7):3487-493 19. Clark DA, Chaouat G, Arck PC, / et al. Cytokine-dependent abortion in CBA × DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase [correction of prothombinase]. J Immunol, 1998,160(2): 545-49 20. Clark DA, Ding JW, Yu G, / et al. Fgl2 prothrombinase expression in mouse trophoblast and decidua triggers abortion but may be countered by OX-2. Mol Hum Reprod, 2001,7(2):185-94 CrossRef 21. Liu M, Mendicino M, Ning Q, / et al. Cytokine-induced hepatic apoptosis is dependent on FGL2/fibroleukin: the role of Sp1/Sp3 and STAT1/PU.1 composite cis elements. J Immunol, 2006,176(11):7028-038 22. Aldhahi W, Hamdy O. Adipokines, inflammation, and the endothelium in diabetes. Curr Diab Rep, 2003,3(4): 293-98 CrossRef 23. Rader DJ. Inflammatory markers of coronary risk. N Eng J Med, 2000,343(16):1179-182 CrossRef 24. Yagihashi S, Wada R, Yamagishi S. Diabetic microangiopathy: pathology and current understanding of its pathogenesis. Verh Dtsch Ges Pathol, 2002,86:91-00 25. Rubler S, Dlugash J, Yuceoglu YZ, / et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol, 1972,30(6):595-02 CrossRef 26. Hamby RI, Zoneraich S, Sherman L. Diabetic cardiomyopathy. JAMA, 1974,229(13):1749-754. CrossRef 27. Dhalla NS, Liu X, Panagia V, / et al. Subcellular remodeling and heart dysfunction in chronic diabetes. Cardiovasc Res, 1998,40(2):239-47 CrossRef
作者单位:Yanping Ding (1) Kun Liu (1) Yan Wang (1) Guanhua Su (1) Heping Deng (2) Qiutang Zeng (1) Yuhua Liao (1) Zhaohui Wang (1)
1. Department of Cardiology, Huazhong University of Science and Technology, Wuhan, 430022, China 2. Department of Ultrasonic Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China